Brief: Lisata Therapeutics Announces Enhancements To Ongoing Phase 2B Ascend Trial Of LSTA1

Lisata Therapeutics

24/05/2023 13:26

May 24 (Reuters) - Lisata Therapeutics Inc  LSTA.O :
    * LISATA THERAPEUTICS ANNOUNCES ENHANCEMENTS TO  ONGOING
PHASE 2B
ASCEND TRIAL OF LSTA1
    * LISATA THERAPEUTICS ANNOUNCES ENHANCEMENTS TO  ONGOING
PHASE 2B
ASCEND TRIAL OF LSTA1
    * LISATA THERAPEUTICS INC - TARGET ENROLLMENT INCREASED TO
155
SUBJECTS WITH ADDITION OF A COHORT TESTING A SECOND DOSE OF
LSTA1
    * LISATA THERAPEUTICS INC - RESULTS TO BE USED TO EXPLORE
POSSIBLE
CONDITIONAL APPROVALS GLOBALLY
    * LISATA THERAPEUTICS INC - FUTILITY ANALYSIS RESULTS
EXPECTED IN
Q3 OF 2023

Source text for Eikon:  ID:nGNXbrxZQy 
Further company coverage:  LSTA.O 

 ((reuters.briefs@thomsonreuters.com;))